▁glob ally , ▁with ▁chron ic ▁lung ▁dise ases ▁( e . g ., ▁ast h ma , ▁chron ic ▁ob struct ive ▁pul mon ary ▁disease , ▁id iop ath ic ▁pul mon ary ▁fib ros is , ▁among ▁others ) ▁and ▁lung ▁cancer ▁causing ▁extensive ▁mor bid ity ▁and ▁mort ality . ▁These ▁conditions ▁are ▁highly ▁heter ogeneous ▁and ▁require ▁an ▁early ▁diagn osis . ▁However , ▁initial ▁sympt oms ▁are ▁n ons pec ific , ▁and ▁the ▁clin ical ▁diagn osis ▁is ▁made ▁late ▁frequently . ▁Over ▁the ▁last ▁few ▁years , ▁personal ized ▁medicine ▁has ▁emer ged ▁as ▁a ▁medical ▁care ▁approach ▁that ▁uses ▁novel ▁technology ▁ ▁aim ing ▁to ▁personal ize ▁treat ments ▁according ▁to ▁the ▁particular ▁patient ' s ▁medical ▁needs . ▁ ▁Can cer ▁genom ics ▁Over ▁recent ▁dec ades ▁cancer ▁research ▁has ▁discovered ▁a ▁great ▁deal ▁about ▁the ▁gen etic ▁variety ▁of ▁types ▁of ▁cancer ▁that ▁appear ▁the ▁same ▁in ▁traditional ▁path ology . ▁There ▁has ▁also ▁been ▁increasing ▁aw aren ess ▁of ▁tum our ▁heter ogene ity , ▁or ▁gen etic ▁divers ity ▁within ▁a ▁single ▁tum our . ▁Among ▁other ▁prospect s , ▁these ▁discover ies ▁raise ▁the ▁possibility ▁of ▁finding ▁that ▁dru gs ▁that ▁have ▁not ▁given ▁good ▁results ▁applied ▁to ▁a ▁general ▁population ▁of ▁cases ▁may ▁yet ▁be ▁successful ▁for ▁a ▁proportion ▁of ▁cases ▁with ▁particular ▁gen etic ▁profiles . ▁ ▁" Person al ized ▁On co - gen om ics " ▁is ▁the ▁application ▁of ▁personal ized ▁medicine ▁to ▁Can